Clinical trial condition

NAFLD

Explore clinical trials studying NAFLD. Study availability and eligibility vary by location and protocol.

175 public trials 36 recruiting studies

Refine in advanced search Browse all conditions

NAFLD trial results

Completed

Efficacy and Safety of Tocovid Suprabio 200mg in Non-alcoholic Fatty Liver (NAFL)

NCT04704063

Conditions: Digestive System Diseases, Fatty Liver, Hepatic Steatosis, +3 more
Locations: KK Bandar Baru Air Itam Pulau Pinang, Malaysia

KK Jalan Perak Pulau Pinang, Malaysia

KK Bayan Baru Pulau Pinang, Malaysia

Hospital Seberang Jaya (CRC) Seberang Jaya, Pulau Pinang, Malaysia

View Trial Details

Completed

Dietary Supplementation With Butyrate in Individuals With Liver Steatosis and Metabolic Syndrome

NCT06398522

Conditions: Digestive System Diseases, Fatty Liver, Glucose Metabolism Disorders, +8 more
Locations: University of Bologna Bologna, BO, Italy

View Trial Details

Completed

A Phase 1 Study of DD01 in Overweight/Obese Subjects With T2DM and NAFLD

NCT04812262

Conditions: Body Weight, Digestive System Diseases, Fatty Liver, +12 more
Locations: Prosciento Chula Vista, California, United States

Southwest General Healthcare Center Fort Myers, Florida, United States

Combined Research Orlando Orlando, Florida, United States

FDI Clinical Research San Juan, Puerto Rico

View Trial Details

Completed

The Study of Lithogenesis Processes in Patients With Non-alcoholic Fatty Liver Disease (NAFLD)

NCT06357052

Conditions: Digestive System Diseases, Fatty Liver, Female Urogenital Diseases, +9 more
Locations: Fondazione Policlinico A.Gemelli IRCCS Roma, Italy

View Trial Details

Completed

Postprandial VLDL-triglyceride Metabolism in Type 2 Diabetes Patients With and Without NAFLD

NCT05044130

Conditions: Diabetes Mellitus, Diabetes Mellitus, Type 2, Digestive System Diseases, +9 more
Locations: Department of Endocrinology and Internal Medicine Aarhus N, Denmark

View Trial Details

Completed

Can Fecal Calprotectin Be Used as a Biomarker of Non-alcoholic Fatty Liver Disease In Obese Adolescents?

NCT06229184

Conditions: Body Weight, Digestive System Diseases, Fatty Liver, +12 more
Locations: Sisli Hamidiye Etfal Training and Research Hospital Istanbul, Turkey (Türkiye)

View Trial Details

Completed

Ketohexokinase Inhibition in NAFLD

NCT05463575

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: Maastricht University Medical centre Maastricht, Limburg, Netherlands

View Trial Details

Completed

The Role of Dietary Carbohydrate and Fat Availability in the Regulation of Hepatic Lipid Content

NCT04581421

Conditions: Body Weight, Diabetes, Diabetes Mellitus, +19 more
Locations: Amalie London Hvidovre, Denmark

View Trial Details

Completed

Efficacy and Tolerability of Lubiprostone in Patients With Nonalcoholic Fatty Liver Disease

NCT05768334

Conditions: Digestive System Diseases, Fatty Liver, Liver Diseases, +2 more
Locations: National Hepatology and Tropical Medicine Research Institute Cairo, Egypt

View Trial Details

Completed

The Visceral Adiposity Measurement and Observation Study

NCT05383456

Conditions: Acquired Immunodeficiency Syndrome, BMI, Blood-Borne Infections, +47 more
Locations: Ruane Clinical Research Los Angeles, California, United States

AIDS Healthcare Foundation Fort Lauderdale, Florida, United States

AIDS Healthcare Foundation Miami Beach, Florida, United States

AIDS Healthcare Foundation Miami Beach, Florida, United States

View Trial Details

NAFLD

NAFLD trial results

Related conditions